Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis
Clinical trial NCT05110638 · COMPLETED
Trial details
- NCT number
- NCT05110638
- Sponsor
- SATO Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2022-05-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.